Prognostic value of PDL1 expression in pancreatic cancer-Reference-Cited by-同舟云学术

Prognostic value of PDL1 expression in pancreatic cancer

Published:2016-08-29 Issue:44 Volume:7 Page:71198-71210
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Birnbaum David J.¹²³,Finetti Pascal¹,Lopresti Alexia¹,Gilabert Marine⁴⁵,Poizat Flora⁴⁶,Turrini Olivier³⁴⁷,Raoul Jean-Luc⁴⁵,Delpero Jean-Robert³⁴⁷,Moutardier Vincent²,Birnbaum Daniel¹³,Mamessier Emilie¹⁴,Bertucci François¹³⁴⁵

Affiliation:

1. Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, INSERM, CNRS, Université Aix-Marseille, Marseille, France

2. Département de Chirurgie Générale et Viscérale, AP-HM, Marseille, France

3. Faculté de Médecine, Aix-Marseille Université, Marseille, France

4. Equipe de Médecine Translationelle Hépato-gastro-entérologie, Institut Paoli-Calmettes, Marseille, France

5. Département d'Oncologie Médicale, Institut Paoli-Calmettes, Marseille, France

6. Département d'Anatomopathologie, Institut Paoli-Calmettes, Marseille, France

7. Département d'Oncologie Chirurgicale, Institut Paoli-Calmettes, Marseille, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of PD-L1 promoter methylation combined with immunogenic context in pancreatic ductal adenocarcinoma;Cancer Immunology, Immunotherapy;2024-06-04

2. VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma;Frontiers in Oncology;2024-04-03

3. Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review;Hepatobiliary Surgery and Nutrition;2024-02

4. Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer;Current Drug Targets;2023-12

5. Pyroptosis-related gene signature: A predictor for overall survival, immunotherapy response, and chemosensitivity in patients with pancreatic adenocarcinoma;Heliyon;2023-12